About Tissue Regenix ( www.tissueregenix.com ) Tissue Regenix is a leading medical devices company in the field of regenerative medicine. The company s patented decellularisation ( dCELL® ) technology removes DNA and other cellular material from animal and human soft tissue leaving an acellular tissue scaffold which is not rejected by the patient s body and can then be used to repair diseased or worn-out body parts. Current applications address many critical clinical needs such as sports medicine, heart valve replacement and wound care. In August 2017 Tissue Regenix acquired CellRight Technologies®, a biotech company that specializes in regenerative medicine and is dedicated to the development of innovative osteoinductive and soft tissue scaffolds that enhance healing opportunities of defects created by trauma and disease. CellRight s human osteobiologics may be used in spine, trauma, general orthopaedic, foot & ankle, dental,
San-antonio
Texas
United-states
Ben-maddison-alex
Daniel-lee
David-cocke
Alice-woodings-paul-mcmanus
Stifel-nicolaus-europe-limited-nominated-adviser
Walbrook-pr-ltd
Tissue-regenix-group
San-antonio-texas
Chief-executive-officer